×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

FARALLON CAPITAL MANAGEMENT LLC

AUM: $42.65 B
13-F Portfolio Value: $23.18 B
Last 13-F Filed: Q2 2025
Concentration in top 10: 45.86%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
BPMCBLUEPRINT MEDICINES CORP-4,000Exited13F
CARACARA THERAPEUTICS INC-129,685Exited13F
CHECHEMED CORP NEW-400Exited13F
DFSDISCOVER FINL SVCS-4,780,000Exited13F
ELANELANCO ANIMAL HEALTH INC-16,000Exited13F
FBRXFORTE BIOSCIENCES INC-70,429Exited13F
ITCIINTRA-CELLULAR THERAPIES INC-3,055,000Exited13F
IBBISHARES TR (Put)-3,600,000Exited13F
JNPRJUNIPER NETWORKS INC-295,000Exited13F
A105PSMARBLEGATE ACQUISITION CORP-150,000Exited13F
GATEWMARBLEGATE ACQUISITION CORP-1,485,000Exited13F
RXSTRXSIGHT INC-175,000Exited13F
SPYSPDR S&P 500 ETF TR (Put)-3,300,000Exited13F
SRPTSAREPTA THERAPEUTICS INC-2,341,424Exited13F
SIMOSILICON MOTION TECHNOLOGY CO-29,298Exited13F
SGISOMNIGROUP INTERNATIONAL INC-1,326,242Exited13F
TMDXTRANSMEDICS GROUP INC-3,000Exited13F
XUNITED STATES STL CORP NEW-2,135,000Exited13F
ZYMEZYMEWORKS INC-400,000Exited13F
BYNDBEYOND MEAT INC-19,000Exited13F
BHVNBIOHAVEN LTD-4,813,167Exited13F